Filter posts

Patents Are The Lifeblood of Biotechnology

Strong patents are the lifeblood of the biotechnology industry. They are critical in ensuring a …

Biotech is key to Achieving International Trilateral Group’s Goals

This week in Geneva three key UN agencies are meeting to address and advance their …

New Infographic: Balancing Need for Innovation with Competition

It is an underreported fact that the time it takes for a generic medicine to …

Important South Dakota Biologics Substitution Bill Heads to Governor's Desk

One of BIO’s top priorities is passage of state laws that establish consistent standards for …

Former Senator Kyl: Abuse of the Patent Review Hurts American Innovation

Earlier this week The Hill ran an op-ed by Former Arizona Senator Jon Kyl in …

Biotech Industry Establishes a Much-Needed Presence in Geneva

Multilateral Organizations, based in Geneva, Switzerland, including the World Health Organization (WHO), World Intellectual Property …

DEA Drug Take Back Day Breaks Collection Record

Last week, the Drug Enforcement Administration’s 14th Prescription Drug Take Back Day collected a record-setting …

Jim Greenwood Talks Biotech Innovation With Bloomberg Radio

While in Boston this week, BIO CEO Jim Greenwood sat down with Bloomberg Boston Bureau …

ONE HEALTH event discusses solutions and innovations in biotechnology in Brazil

Joseph Damond, Executive Vice President of International Affairs at BIO led a keynote discussion on …

BIO to Senate Judiciary: Stop Abuses at PTO

Gamesmanship of the United States Patent and Trademark Office’s (PTO) Inter Partes Review (IPR) process …